Volume Analysis
Futures
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 2,365.9 | 2,343.34 |
| R2 | 2,398.9 | 2,364.56 |
| R3 | 2,455.8 | 2,398.9 |
| PP | 2,309 | 2,309 |
| S1 | 2,365.9 | 2,343.34 |
| S2 | 2,219.1 | 2,253.44 |
| S3 | 2,186.1 | 2,219.1 |
Ratios
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| ROCE | - | 6.29 | - | 6.96 | - |
| ROE | - | 6.63 | - | 6.15 | - |
| EPS | 26.07 | -2.62 | 10 | -26.19 | 11.7 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|---|---|---|---|---|
| No data available | |||||
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets....
ISIN :INE935A01035
Registered Office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road
Contact number
+ 91-22-40189999
Registrars
KFin Techologies Ltd
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Contact number
+ 91-40-67162222
Management
Glenn Saldanha (Chairman)
Glenn Saldanha (Director)
Open IPO’s
Price Range
₹750 - ₹788
Min. Quantity
19 Shares
Min. investment
₹14,972
Closes on
August 25, 2026
Price Range
₹285 - ₹300
Min. Quantity
50 Shares
Min. investment
₹15,000
Closes on
August 24, 2026
FAQs
The share price of Glenmark Pharmaceuticals Ltd on the BSE is - as on -